FR2845597B1 - Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer - Google Patents

Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer

Info

Publication number
FR2845597B1
FR2845597B1 FR0212633A FR0212633A FR2845597B1 FR 2845597 B1 FR2845597 B1 FR 2845597B1 FR 0212633 A FR0212633 A FR 0212633A FR 0212633 A FR0212633 A FR 0212633A FR 2845597 B1 FR2845597 B1 FR 2845597B1
Authority
FR
France
Prior art keywords
croquered
diosmine
tablet
formulation containing
oral formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0212633A
Other languages
English (en)
Other versions
FR2845597A1 (fr
Inventor
Catherine Meignant
Baron Corinne Vieillard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Innothera SAS
Original Assignee
Laboratoires Innothera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Innothera SAS filed Critical Laboratoires Innothera SAS
Priority to FR0212633A priority Critical patent/FR2845597B1/fr
Priority to EP03780209A priority patent/EP1549326A1/fr
Priority to PCT/FR2003/002973 priority patent/WO2004032942A1/fr
Priority to AU2003288308A priority patent/AU2003288308A1/en
Publication of FR2845597A1 publication Critical patent/FR2845597A1/fr
Application granted granted Critical
Publication of FR2845597B1 publication Critical patent/FR2845597B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
FR0212633A 2002-10-11 2002-10-11 Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer Expired - Fee Related FR2845597B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0212633A FR2845597B1 (fr) 2002-10-11 2002-10-11 Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer
EP03780209A EP1549326A1 (fr) 2002-10-11 2003-10-09 Formulation orale seche a visee phlebotonique et vasculoprotectrice pour le traitement de l'insuffisance veineuse, de la fragilite capillaire et de la crise hemorroidaire, sous forme pharmaceutique de comprime a croquer contenant de la diosmine
PCT/FR2003/002973 WO2004032942A1 (fr) 2002-10-11 2003-10-09 Formulation orale seche a visee phlebotonique et vasculoprotectrice pour le traitement de l'insuffisance veineuse, de la fragilite capillaire et de la crise hemorroidaire, sous forme pharmaceutique de comprime a croquer contenant de la diosmine
AU2003288308A AU2003288308A1 (en) 2002-10-11 2003-10-09 Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212633A FR2845597B1 (fr) 2002-10-11 2002-10-11 Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer

Publications (2)

Publication Number Publication Date
FR2845597A1 FR2845597A1 (fr) 2004-04-16
FR2845597B1 true FR2845597B1 (fr) 2005-03-11

Family

ID=32039633

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0212633A Expired - Fee Related FR2845597B1 (fr) 2002-10-11 2002-10-11 Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer

Country Status (4)

Country Link
EP (1) EP1549326A1 (fr)
AU (1) AU2003288308A1 (fr)
FR (1) FR2845597B1 (fr)
WO (1) WO2004032942A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20050517A1 (it) 2005-03-30 2006-09-30 Therapicon Srl Composizione farmaceutica di una tipica frazione microcristallina di flavonoidi
MD3987C2 (ro) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă
MD3986C2 (ro) * 2009-09-23 2010-07-31 Георге АНГЕЛИЧ Utilizare a Diosminei pentru tratamentul gastropatiilor portale în ciroza hepatică
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
MD4232C1 (ro) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Remediu medicamentos pe bază de troxerutin şi carbazocrom pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă
MD4231C1 (ro) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Remediu medicamentos pe bază de troxerutin şi carbazocrom pentru tratamentul gastropatiilor portale în ciroza hepatică
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3145489A1 (fr) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Formulations d'hormones substitutives combinées naturelles et traitement hormonal substitutif
FR3083980B1 (fr) * 2018-07-20 2021-04-16 Servier Lab Composition pharmaceutique sous la forme d'un comprime a croquer de diosmine ou d'une fraction flavonoique
WO2021123341A1 (fr) 2019-12-20 2021-06-24 Krka, D.D., Novo Mesto Composition comprenant de la diosmine
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2661610B1 (fr) * 1990-05-02 1994-09-30 Rhone Poulenc Sante Nouvelle forme lyophilisee de la diosmine et sa preparation.
FR2661830B1 (fr) * 1990-05-11 1992-09-04 Corbiere Jerome Nouvelle compositions pharmaceutiques a base de flavonoside.
FR2726469B1 (fr) * 1994-11-08 1996-12-13 Adir Composition pharmaceutique pour l'administration orale de flavonoides
FR2774291B1 (fr) * 1998-02-03 2000-04-21 Innothera Lab Sa Specialite pharmaceutique sous forme galenique unitaire de comprimes a croquer ou a sucer, comprenant comme principe actif du fer element
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
IL154144A0 (en) * 2000-07-28 2003-07-31 Immupharm Aps Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract

Also Published As

Publication number Publication date
FR2845597A1 (fr) 2004-04-16
EP1549326A1 (fr) 2005-07-06
AU2003288308A1 (en) 2004-05-04
WO2004032942A1 (fr) 2004-04-22

Similar Documents

Publication Publication Date Title
FR2845597B1 (fr) Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
DK1539126T3 (da) Tabletter indeholdende 250 til 450 mg modafinil
ID28675A (id) Komposisi dosis oral pelepasan diperpanjang yang stabil
ID29468A (id) Komposisi farmasi yang stabil dalam bentuk liofil
ATE372765T1 (de) Feste pharmazeutische formulierungen mit telmisartan
ATE388703T1 (de) Pharmazeutische formulierung des telmisartan natriumsalzes
ITMI991316A0 (it) Composizioni farmaceutiche orali a rilascio modificato di mesalazina
BR0107565A (pt) Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
MA28078A1 (fr) Produits pharmaceutiques contenant des bisphosphonates
EE200200393A (et) Glüburiidi ravimkoostis
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
IS2616B (is) Lyfjablanda sem felur í sér levóþýroxínnatríum
NO20043832L (no) Oral fast losningsformulering av en darlig vannloselig aktiv substans
NO20021898D0 (no) Farmasöytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa
ATE507831T1 (de) Melatonin enthaltende pharmazeutische formulierung
PL354365A1 (en) Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions
ITTO20020672A0 (it) Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
FR2900795B1 (fr) Formulation detergente et desinfectante sous forme solide divisee contenant a titre de principe actif une association pvp iodee/iodure de potassium
ITMI20011457A0 (it) Composizione farmaceutica a rilascio modificato contenente bupropionehc1 come sostanza attiva
AU2003235452A1 (en) Use of hydroxyeicosatetraenoic acid compounds to treat dry mouth
ATA171599A (de) Pharmazeutische zusammensetzung zur abdeckung des grundbedarfs an vitaminen
ITBO20020022A1 (it) Composizioni farmaceutiche per la cura della pelle e il loro impiego
PT1467737E (pt) Composicao farmaceutica orodispersivel de piribedil

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160630